VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
2.780
+0.056 (2.06%)
Apr 28, 2026, 4:00 PM EDT - Market closed
VolitionRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1.73 | 1.23 | 0.78 | 0.31 | 0.09 | Upgrade
|
| Revenue Growth (YoY) | 40.04% | 59.10% | 153.04% | 240.30% | 570.25% | Upgrade
|
| Gross Profit | 1.73 | 1.23 | 0.78 | 0.31 | 0.09 | Upgrade
|
| Selling, General & Admin | 13.38 | 13.85 | 17.21 | 16.75 | 15.4 | Upgrade
|
| Research & Development | 10.08 | 14.41 | 19.55 | 15.33 | 13.02 | Upgrade
|
| Operating Expenses | 23.47 | 28.26 | 36.76 | 32.09 | 28.42 | Upgrade
|
| Operating Income | -21.74 | -27.02 | -35.99 | -31.78 | -28.33 | Upgrade
|
| Interest Expense | -2.49 | -0.34 | -0.22 | -0.17 | -0.16 | Upgrade
|
| Interest & Investment Income | 0 | 0.01 | 0.09 | 0.13 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.72 | 0.13 | 0.45 | 1.23 | 1.52 | Upgrade
|
| EBT Excluding Unusual Items | -23.51 | -27.22 | -35.66 | -30.6 | -26.96 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | -0.03 | -0.02 | - | -0.03 | Upgrade
|
| Pretax Income | -23.5 | -27.26 | -35.68 | -30.6 | -26.99 | Upgrade
|
| Earnings From Continuing Operations | -23.5 | -27.26 | -35.68 | -30.6 | -26.99 | Upgrade
|
| Minority Interest in Earnings | 0.15 | 0.29 | 0.36 | 0.33 | 0.18 | Upgrade
|
| Net Income | -23.36 | -26.97 | -35.32 | -30.27 | -26.81 | Upgrade
|
| Net Income to Common | -23.36 | -26.97 | -35.32 | -30.27 | -26.81 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 4 | 4 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 4 | 4 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 23.46% | 21.47% | 28.70% | 5.12% | 16.29% | Upgrade
|
| EPS (Basic) | -4.37 | -6.23 | -9.92 | -10.94 | -10.18 | Upgrade
|
| EPS (Diluted) | -4.37 | -6.23 | -9.92 | -10.94 | -10.18 | Upgrade
|
| Free Cash Flow | -19.77 | -26.17 | -19.15 | -16.85 | -21.83 | Upgrade
|
| Free Cash Flow Per Share | -3.70 | -6.05 | -5.38 | -6.09 | -8.29 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -1258.47% | -2190.90% | -4641.77% | -10372.36% | -31468.96% | Upgrade
|
| Profit Margin | -1352.16% | -2186.27% | -4555.52% | -9879.11% | -29782.49% | Upgrade
|
| Free Cash Flow Margin | -1144.67% | -2121.68% | -2469.59% | -5498.81% | -24243.32% | Upgrade
|
| EBITDA | -20.75 | -25.91 | -34.84 | -30.84 | -27.39 | Upgrade
|
| D&A For EBITDA | 0.98 | 1.11 | 1.15 | 0.94 | 0.95 | Upgrade
|
| EBIT | -21.74 | -27.02 | -35.99 | -31.78 | -28.33 | Upgrade
|
| Revenue as Reported | 1.73 | 1.23 | 0.78 | 0.31 | 0.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.